Quality peptides.
Your next
brand opportunity.
Explore peptide sourcing with documented origin and private-label options through a dedicated marketing partner.
From first conversation
to your product line.
Connect with supply partners, explore available products, and discuss a private-label program built around your business needs.
Product availability, testing documentation, minimum order quantities, and terms are confirmed by the supplier before an order is accepted.
Tell us what you're looking for
Share your product interests, quantities, and branding goals.
Review the details
Request specifications, available batch documentation, pricing, and lead times.
Confirm with the supplier
The supplier reviews eligibility, intended use, and fulfillment requirements before confirming your request.
Products & pricing.
October 20, 2026 · All prices in USD per unit.
Mix-and-match SKUs qualify toward the total. For research purposes only. Products not for human consumption. Descriptions explain scientific context, not instructions for use. Research findings are not proven medical benefits. Approval of a named prescription medicine does not apply to these catalog products. Multi-quantity sizes identify supplied blends.
GLP / METABOLIC
| Product | Description & research focus | Size | Wholesale price |
|---|---|---|---|
| Semaglutide | GLP-1 compound involved in appetite and blood sugar regulation. Specific prescription medicines are approved for diabetes or weight management; this catalog item is research-only. | 5mg | $18.20 |
| Semaglutide | GLP-1 compound involved in appetite and blood sugar regulation. Specific prescription medicines are approved for diabetes or weight management; this catalog item is research-only. | 10mg | $28.60 |
| Semaglutide | GLP-1 compound involved in appetite and blood sugar regulation. Specific prescription medicines are approved for diabetes or weight management; this catalog item is research-only. | 15mg | $39.00 |
| Semaglutide | GLP-1 compound involved in appetite and blood sugar regulation. Specific prescription medicines are approved for diabetes or weight management; this catalog item is research-only. | 20mg | $49.40 |
| Tirzepatide | GIP/GLP-1 compound involved in appetite and blood sugar regulation. Specific prescription medicines are approved for diabetes or weight management; this catalog item is research-only. | 10mg | $31.20 |
| Tirzepatide | GIP/GLP-1 compound involved in appetite and blood sugar regulation. Specific prescription medicines are approved for diabetes or weight management; this catalog item is research-only. | 15mg | $41.60 |
| Tirzepatide | GIP/GLP-1 compound involved in appetite and blood sugar regulation. Specific prescription medicines are approved for diabetes or weight management; this catalog item is research-only. | 20mg | $52.00 |
| Tirzepatide | GIP/GLP-1 compound involved in appetite and blood sugar regulation. Specific prescription medicines are approved for diabetes or weight management; this catalog item is research-only. | 30mg | $70.20 |
| Tirzepatide | GIP/GLP-1 compound involved in appetite and blood sugar regulation. Specific prescription medicines are approved for diabetes or weight management; this catalog item is research-only. | 40mg | $83.20 |
| Retatrutide | Triple GIP/GLP-1/glucagon receptor compound studied for obesity and blood sugar control. Investigational; not an approved treatment. | 10mg | $31.20 |
| Retatrutide | Triple GIP/GLP-1/glucagon receptor compound studied for obesity and blood sugar control. Investigational; not an approved treatment. | 20mg | $52.00 |
| Retatrutide | Triple GIP/GLP-1/glucagon receptor compound studied for obesity and blood sugar control. Investigational; not an approved treatment. | 30mg | $70.20 |
| Retatrutide | Triple GIP/GLP-1/glucagon receptor compound studied for obesity and blood sugar control. Investigational; not an approved treatment. | 40mg | $83.20 |
| Cagrilintide | Amylin-like peptide studied for appetite regulation and weight management. Research findings do not establish an approved use for this item. | 5mg | $36.40 |
| Cagrilintide | Amylin-like peptide studied for appetite regulation and weight management. Research findings do not establish an approved use for this item. | 10mg | $62.40 |
| AOD-9604 | Modified growth hormone fragment studied for fat metabolism, mainly in laboratory and animal models. Human weight-loss benefits are not established. | 5mg | $36.40 |
| AOD-9604 | Modified growth hormone fragment studied for fat metabolism, mainly in laboratory and animal models. Human weight-loss benefits are not established. | 10mg | $62.40 |
| HGH Frag 176-191 | Growth hormone fragment used in fat-metabolism research. Not established as a weight-loss treatment. | 5mg | $39.00 |
GH / GROWTH FACTORS
| Product | Description & research focus | Size | Wholesale price |
|---|---|---|---|
| Ipamorelin | Peptide studied for growth hormone release. Human safety information is limited. | 5mg | $15.60 |
| Ipamorelin | Peptide studied for growth hormone release. Human safety information is limited. | 10mg | $20.80 |
| CJC-1295 | Growth hormone-releasing hormone analog studied for hormone signaling. Confirm the exact form with the supplier. | 5mg | $28.60 |
| CJC-1295 | Growth hormone-releasing hormone analog studied for hormone signaling. Confirm the exact form with the supplier. | 10mg | $46.80 |
| CJC-1295 W DAC | CJC-1295 with a drug affinity complex (DAC), designed for longer activity in growth hormone research. | 5mg | $49.40 |
| CJC-1295 W DAC | CJC-1295 with a drug affinity complex (DAC), designed for longer activity in growth hormone research. | 10mg | $78.00 |
| Ipa/CJC | Ipamorelin and CJC blend for growth hormone signaling research. Confirm the CJC form and blend composition. | 5/5mg | $33.80 |
| Ipa/CJC | Ipamorelin and CJC blend for growth hormone signaling research. Confirm the CJC form and blend composition. | 10/10mg | $65.00 |
| Tesamorelin | Growth hormone-releasing factor analog. A specific prescription formulation treats excess abdominal fat in adults with HIV-related lipodystrophy; this research item is not that approved medicine. | 5mg | $26.00 |
| Tesamorelin | Growth hormone-releasing factor analog. A specific prescription formulation treats excess abdominal fat in adults with HIV-related lipodystrophy; this research item is not that approved medicine. | 10mg | $49.40 |
| Tesamorelin | Growth hormone-releasing factor analog. A specific prescription formulation treats excess abdominal fat in adults with HIV-related lipodystrophy; this research item is not that approved medicine. | 20mg | $93.60 |
| Tesa/Ipa | Tesamorelin and ipamorelin blend for growth hormone signaling research. Combined clinical benefits are not established. | 10/5mg | $65.00 |
| AOD/Tesa | AOD-9604 and tesamorelin blend for metabolic and hormone research. Combined clinical benefits are not established. | 5/5mg | $57.20 |
| Sermorelin | Growth hormone-releasing hormone fragment studied for stimulating growth hormone release. This research item is not a prescribed treatment. | 5mg | $23.40 |
| Sermorelin | Growth hormone-releasing hormone fragment studied for stimulating growth hormone release. This research item is not a prescribed treatment. | 10mg | $41.60 |
| GHRP-2 | Growth hormone-releasing peptide used in hormone research. FDA has identified safety concerns. | 5mg | $15.60 |
| GHRP-2 | Growth hormone-releasing peptide used in hormone research. FDA has identified safety concerns. | 10mg | $20.80 |
| GHRP-6 | Growth hormone-releasing peptide used in hormone and appetite research. FDA has identified blood sugar and other safety concerns. | 5mg | $15.60 |
| GHRP-6 | Growth hormone-releasing peptide used in hormone and appetite research. FDA has identified blood sugar and other safety concerns. | 10mg | $20.80 |
| IGF-1 LR3 | Modified insulin-like growth factor used in cell-growth and signaling research. Not an approved muscle-building treatment. | 1mg | $49.40 |
RECOVERY & HEALING
| Product | Description & research focus | Size | Wholesale price |
|---|---|---|---|
| BPC-157 | Experimental peptide studied for tissue-repair processes, mainly in animals. Human healing benefits and safety are not established. | 5mg | $18.20 |
| BPC-157 | Experimental peptide studied for tissue-repair processes, mainly in animals. Human healing benefits and safety are not established. | 10mg | $26.00 |
| BPC-157 | Experimental peptide studied for tissue-repair processes, mainly in animals. Human healing benefits and safety are not established. | 15mg | $33.80 |
| BPC-157 | Experimental peptide studied for tissue-repair processes, mainly in animals. Human healing benefits and safety are not established. | 20mg | $41.60 |
| TB-500 | Thymosin-related research peptide associated with cell movement and tissue-repair studies. Confirm its exact sequence; human healing benefits are not established. | 5mg | $26.00 |
| TB-500 | Thymosin-related research peptide associated with cell movement and tissue-repair studies. Confirm its exact sequence; human healing benefits are not established. | 10mg | $41.60 |
| BPC-TB | BPC-157 and TB-500 blend for tissue-repair research. Human benefits and safety of the combination are not established. | 5/5mg | $39.00 |
| BPC-TB | BPC-157 and TB-500 blend for tissue-repair research. Human benefits and safety of the combination are not established. | 10/10mg | $62.40 |
| BPC-TB | BPC-157 and TB-500 blend for tissue-repair research. Human benefits and safety of the combination are not established. | 20/20mg | $109.20 |
| GHK-Cu | Copper-binding peptide studied for skin biology, collagen and tissue remodeling. Topical findings do not establish injectable safety or effectiveness. | 50mg | $15.60 |
| GHK-Cu | Copper-binding peptide studied for skin biology, collagen and tissue remodeling. Topical findings do not establish injectable safety or effectiveness. | 100mg | $23.40 |
| ARA-290 | Erythropoietin-derived peptide studied for nerve symptoms and tissue-protection pathways. Clinical use remains investigational. | 16mg | $39.00 |
PROPRIETARY BLENDS
Supplier-named blends; exact contents to be confirmed.
| Product | Description & research focus | Size | Wholesale price |
|---|---|---|---|
| GLOW | Supplier-named research blend. Exact ingredients and proportions must be confirmed before describing its research applications. | 50/10/10mg | $44.20 |
| GLOW | Supplier-named research blend. Exact ingredients and proportions must be confirmed before describing its research applications. | 100/20/20mg | $85.80 |
| KLOW | Supplier-named research blend. Exact ingredients and proportions must be confirmed before describing its research applications. | 50/10mg | $54.60 |
| KLOW | Supplier-named research blend. Exact ingredients and proportions must be confirmed before describing its research applications. | 100/20mg | $104.00 |
IMMUNE
| Product | Description & research focus | Size | Wholesale price |
|---|---|---|---|
| Thymosin Alpha-1 | Peptide studied for immune signaling. This catalog item has no established U.S. approved therapeutic use. | 10mg | $44.20 |
| LL-37 | Human antimicrobial peptide studied for immune responses and microbial interactions. Human treatment safety is not established. | 5mg | $39.00 |
| KPV | Short peptide investigated in inflammation research. Human treatment benefits and safety are not established. | 10mg | $20.80 |
LONGEVITY
| Product | Description & research focus | Size | Wholesale price |
|---|---|---|---|
| SS-31 | Also called elamipretide; studied for mitochondrial function. A specific prescription medicine is approved for Barth syndrome; this research item is not that medicine or an anti-aging treatment. | 10mg | $31.20 |
| SS-31 | Also called elamipretide; studied for mitochondrial function. A specific prescription medicine is approved for Barth syndrome; this research item is not that medicine or an anti-aging treatment. | 30mg | $72.80 |
| SS-31 | Also called elamipretide; studied for mitochondrial function. A specific prescription medicine is approved for Barth syndrome; this research item is not that medicine or an anti-aging treatment. | 50mg | $114.40 |
| MOTS-C | Mitochondria-derived peptide studied for energy metabolism and cellular stress responses. Human treatment benefits are not established. | 10mg | $26.00 |
| MOTS-C | Mitochondria-derived peptide studied for energy metabolism and cellular stress responses. Human treatment benefits are not established. | 20mg | $46.80 |
| Epithalon | Short experimental peptide studied in cellular aging research. Life-extension benefits in people are not established. | 10mg | $15.60 |
| Epithalon | Short experimental peptide studied in cellular aging research. Life-extension benefits in people are not established. | 50mg | $52.00 |
| FOXO4-DRI | Experimental peptide studied for targeting senescent cells in laboratory and animal models. Not a proven anti-aging treatment. | 10mg | $130.00 |
NEURO / COGNITIVE
| Product | Description & research focus | Size | Wholesale price |
|---|---|---|---|
| Semax | Experimental peptide studied for nervous-system signaling. Cognitive benefits and safety for this product are not established. | 10mg | $18.20 |
| Semax | Experimental peptide studied for nervous-system signaling. Cognitive benefits and safety for this product are not established. | 30mg | $39.00 |
| Semax Acetyl | Acetylated Semax variant for experimental research. Findings for Semax cannot automatically be applied to this variant. | 30mg | $44.20 |
| Selank | Experimental peptide studied in stress-response and nervous-system research. Clinical benefits and safety for this product are not established. | 10mg | $18.20 |
| Selank Acetyl | Acetylated Selank variant for experimental research. Findings for Selank cannot automatically be applied to this variant. | 10mg | $23.40 |
| Semax/Selank | Semax and Selank research blend. Human benefits and safety of the combination are not established. | 30/10mg | $46.80 |
| Dihexa | Experimental compound studied for nerve-cell connections in preclinical models. Human safety and cognitive benefits are not established. | 5mg | $13.00 |
| Dihexa | Experimental compound studied for nerve-cell connections in preclinical models. Human safety and cognitive benefits are not established. | 10mg | $18.20 |
| P-21 | Supplier-listed research peptide. Confirm its exact sequence and whether it corresponds to published P021 research before assigning uses. | 5mg | $62.40 |
| DSIP | Delta sleep-inducing peptide, investigated in sleep research. Effectiveness as a sleep treatment is not established. | 5mg | $18.20 |
| VIP | Vasoactive intestinal peptide, involved in blood-vessel, digestive and immune signaling. This research item has no established treatment use. | 5mg | $23.40 |
| VIP | Vasoactive intestinal peptide, involved in blood-vessel, digestive and immune signaling. This research item has no established treatment use. | 10mg | $41.60 |
SPECIALTY
| Product | Description & research focus | Size | Wholesale price |
|---|---|---|---|
| Melanotan-II | Melanocortin receptor compound studied for pigmentation and other effects. Not an approved tanning product; serious adverse events have been reported. | 10mg | $20.80 |
| PT-141 | Also called bremelanotide; studied for sexual-response signaling. A specific prescription formulation has a limited approved indication; this research item is not that medicine. | 10mg | $23.40 |
| Oxytocin | Hormone involved in uterine contractions and milk release, also studied in social-behavior research. This catalog item is not an approved prescription formulation. | 10mg | $20.80 |
| Gonadorelin | Gonadotropin-releasing hormone used in reproductive-hormone research. This catalog item is not an approved prescription formulation. | 10mg | $28.60 |
| Kisspeptin-10 | Peptide studied for reproductive-hormone signaling. Human treatment benefits and safety for this item are not established. | 10mg | $26.00 |
| SNAP-8 | Supplier-listed cosmetic research peptide. Confirm its identity and supporting topical data; no injectable or wrinkle-treatment benefit is established for this item. | 10mg | $18.20 |
BIOREGULATORS
| Product | Description & research focus | Size | Wholesale price |
|---|---|---|---|
| Pinealon | Short peptide studied in experimental nerve-cell and cellular-stress research. Clinical benefits are not established. | 20mg | $26.00 |
| Ovagen | Supplier-listed bioregulator research product. Confirm its peptide sequence and supporting studies; no clinical use is established for this catalog item. | 20mg | $26.00 |
| Chonluten | Supplier-listed bioregulator research product. Confirm its peptide sequence and supporting studies; no clinical use is established for this catalog item. | 20mg | $26.00 |
| Prostamax | Supplier-listed bioregulator research product. Confirm its peptide sequence and supporting studies; no clinical use is established for this catalog item. | 20mg | $26.00 |
| Cortagen | Peptide studied in brain-tissue culture research. Findings do not establish a treatment benefit in people. | 20mg | $26.00 |
| Vesugen | Short peptide studied in experimental cell-regulation research. Clinical benefits are not established. | 20mg | $26.00 |
| Thymalin | Supplier-listed bioregulator research product. Confirm its peptide sequence and supporting studies; no clinical use is established for this catalog item. | 20mg | $26.00 |
| Cardiogen | Supplier-listed bioregulator research product. Confirm its peptide sequence and supporting studies; no clinical use is established for this catalog item. | 20mg | $26.00 |
| Testagen | Supplier-listed bioregulator research product. Confirm its peptide sequence and supporting studies; no clinical use is established for this catalog item. | 20mg | $26.00 |
| Vilon | Short peptide studied in thymus-tissue and immune-cell research. Clinical benefits are not established. | 20mg | $26.00 |
| Cartalax | Supplier-listed bioregulator research product. Confirm its peptide sequence and supporting studies; no clinical use is established for this catalog item. | 20mg | $26.00 |
| Crystagen | Supplier-listed bioregulator research product. Confirm its peptide sequence and supporting studies; no clinical use is established for this catalog item. | 20mg | $26.00 |
| Pancragen | Supplier-listed bioregulator research product. Confirm its peptide sequence and supporting studies; no clinical use is established for this catalog item. | 20mg | $26.00 |
| Vesilute | Supplier-listed bioregulator research product. Confirm its peptide sequence and supporting studies; no clinical use is established for this catalog item. | 20mg | $26.00 |
| Livagen | Peptide studied in liver-tissue culture research. Findings do not establish a treatment benefit in people. | 20mg | $26.00 |
| Bronchogen | Supplier-listed bioregulator research product. Confirm its peptide sequence and supporting studies; no clinical use is established for this catalog item. | 20mg | $26.00 |
SUPPLIES
| Product | Description & research focus | Size | Wholesale price |
|---|---|---|---|
| Bacteriostatic Water | Preserved water supplied as a diluent. Confirm composition, sterility and compatibility from supplier documentation; it is not a peptide. | 10ml | $7.80 |
Availability and final terms are subject to supplier confirmation.
Request a wholesale order ↗About these descriptions & sources
Descriptions reviewed October 20, 2026. No dosing, injection or self-treatment guidance is provided. Supplier-named blends and products with unconfirmed identities require documentation before specific applications can be stated.
FDA peptide safety information · FDA GLP-1 information · Retatrutide trial · Cagrilintide trial · Elamipretide information
Start the
conversation.
Ask a question, explore private label, or submit an order request. Include your email so we can respond.
Los Angeles, CA
No payment is collected here. An order request is not a confirmed purchase.
Important information.
Effective October 18, 2026 · Version 2026-10-18.2. These terms govern use of this marketing website and submission of inquiries. Product sales require a separate supplier agreement.
Product disclosures & permitted use
Marketing role. TwoSix Consulting operates this website as an independent marketing intermediary. Contact: nrn262@gmail.com. The operator introduces prospective business customers to suppliers; this site does not manufacture, prescribe, compound, dispense, or administer products. A marketing or referral fee may be earned in connection with an introduction or resulting transaction. The supplier's identity and role must be disclosed before any transaction.
No medical claims or authorization. Content is business information, not medical advice. No claim is made that any product offered through an introduction is FDA-approved, safe, effective, sterile, or suitable for a particular use. Do not rely on this website for diagnosis, treatment, dosing, preparation, or administration instructions. No clinician-patient relationship is created.
Product classification matters. Materials expressly classified as research use only must not be used in humans or animals or for clinical, diagnostic, therapeutic, or household use. A research-use label does not authorize an otherwise unlawful sale or use. Any lawful prescription or compounded-drug transaction must be handled separately by appropriately licensed parties, subject to applicable prescriptions, licenses, and product-specific restrictions. This form does not authorize such activity.
Origin, purity & testing. U.S.-origin statements apply only where supported by product-specific manufacturing records that substantiate the exact claim. Packaging, distribution, or testing in the United States alone does not establish that a product is made in the USA. A 99% purity statement applies only to the identified batch and reported test method supported by matching documentation. A certificate of analysis is not proof of FDA approval, clinical safety, sterility, potency, or suitability for administration. Request and independently review applicable specifications, batch records, and testing before proceeding.
Private label. Branding availability does not establish regulatory permission to distribute a product. Label artwork, claims, intellectual-property rights, required warnings, licenses, traceability, and product classification must be reviewed before production. No minimum quantities, exclusivity, sales results, or lead times are guaranteed on this website.
Website Terms & order requests
Eligibility & assent. You must be at least 18 and authorized to represent your business. By checking the acceptance box and submitting, you agree to this version of the Website Terms. Provide accurate information and use the website only for lawful purposes. Do not submit patient records, payment card information, prescriptions, or other sensitive medical information.
No automatic purchase. A submission, reference number, automated receipt, discussion, or quotation is not acceptance of a product order. No payment is collected on this site. The supplier must separately confirm product classification, customer eligibility, specifications, quantity, price, taxes, shipping, delivery estimates, cancellation and return terms, and applicable sales terms in writing before a binding purchase. Ask for those terms before paying. Do not send payment based solely on a website submission.
Independent parties. Suppliers are responsible for their own manufacturing, testing, labeling, licensing, sale, and fulfillment obligations. Customers remain responsible for lawful receipt, storage, handling, use, and any downstream activities. The operator cannot bind an independent supplier. This allocation does not remove the operator's own legal responsibilities or excuse misleading statements.
Website warranties. To the extent permitted by law, website information and introduction services are provided as available without implied warranties of merchantability, fitness for a particular purpose, or non-infringement. Availability, timelines, and commercial results are not guaranteed. This provision does not override an express written warranty, supplier sales terms, or a nonwaivable legal protection.
Limitation of liability. To the extent permitted by law, the operator is not liable for indirect, consequential, incidental, special, or punitive losses, including lost profits, arising from use of this website or introduction services. Nothing excludes or limits liability for fraud, willful misconduct, gross negligence, personal injury where limitation is prohibited, statutory remedies, or other liability that cannot lawfully be excluded. These terms do not release a supplier or operator from obligations imposed by law.
Responsibility for misuse. To the extent permitted by law, a business submitting a request agrees to indemnify the operator for third-party claims, reasonable costs, and damages to the extent caused by that business's unlawful use of the website, unauthorized product claims, infringement, or material breach of these terms. This obligation does not cover the operator's own negligence, misconduct, or violation of law.
Site integrity & intellectual property. Do not disrupt the website, submit malicious content, harvest personal information, or misrepresent your identity. Website branding and content may not be reused commercially without permission or another lawful basis. Your submission grants only the permission needed to handle your inquiry; it does not transfer your branding ownership.
Changes & disputes. Material changes will be posted with a revised effective date and apply prospectively. Existing submissions remain subject to the version accepted when submitted unless otherwise agreed. Applicable law determines governing law and venue; these terms do not impose arbitration or waive class actions. If a provision is unenforceable, the remainder applies to the extent lawful. Nonwaivable rights are preserved.
Privacy Notice & notice at collection
Information collected. We collect the name, business name, email, optional phone number, product interests, destination, messages, and acknowledgments you submit, together with a reference number, submission time, and accepted terms version. Hosting and access providers may process technical information such as IP address, browser details, authentication information, and security logs under their own policies.
Purposes & recipients. Submission information is used to respond, assess a business request, arrange an introduction you request, maintain records, prevent abuse, and meet legal obligations. Data is stored with hosting/storage service providers. Relevant information may be disclosed to a prospective supplier for a requested introduction, advisers supporting operations, or authorities when legally required. It may also be transferred in a business reorganization subject to applicable law. Submission does not authorize unrelated email campaigns, automated marketing calls, or marketing text messages.
Tracking & sale. This website's application does not use advertising pixels, analytics trackers, or sell submitted personal information. It does not share submissions for cross-context behavioral advertising. Hosting and sign-in services may use necessary security or authentication technologies. The application does not respond differently to Do Not Track signals; it does not initiate advertising tracking when a Global Privacy Control signal is present.
Retention & security. Records are retained for the period reasonably needed to handle requests, maintain necessary business records, resolve disputes, and comply with law; the period depends on request status and legal obligations. Access should be restricted to authorized people. No internet transmission or storage system can be guaranteed secure. Do not provide sensitive health, financial, or identification information.
Your requests. Email nrn262@gmail.com or use the Email inquiry form, select “Privacy request,” and describe a request to access, correct, delete, or stop further contact about your information. Identity verification may be needed; do not send government identification through the form. We will handle requests within time periods required by applicable law, subject to lawful exceptions, without unlawful discrimination. This notice does not condition statutory rights on accepting the Website Terms.
Children, location & updates. This site is for adults acting on behalf of businesses, not children. Submitted information may be processed in the United States and other locations used by service providers. Updates are identified by a new effective date. A supplier receiving an introduction will have its own privacy practices; review them before proceeding.